Literature DB >> 27882625

Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology.

Samuel Lamarre Skulsky1, Barry O'Sullivan2, Orla McArdle3, Mary Leader4, Muireann Roche5, Peter J Conlon6, James Paul O'Neill7.   

Abstract

Cutaneous squamous cell carcinoma (SCC) is a malignancy that arises from epidermal keratinocytes. Although the majority of cutaneous SCC cases are easily treated without further complication, some behave more aggressively and carry a poor prognosis. These "high-risk" cutaneous SCCs commonly originate in the head and neck and have an increased tendency toward recurrence, local invasion, and distant metastasis. Factors for high-risk cutaneous SCC include large size (>2 cm), a deeply invasive lesion (>2 mm), incomplete excision, high-grade/desmoplastic lesions, perineural invasion (PNI), lymphovascular invasion, immunosuppression, and high-risk anatomic locations. Both the National Comprehensive Cancer Network® (NCCN® ) and the American Joint Committee on Cancer (AJCC) identify several of these high-risk features of cutaneous SCC. The purpose of this article was to review the high-risk features included in these guidelines, as well as their notable discrepancies and omissions. We also provide a brief overview of current prophylactic measures, surgical options, and adjuvant therapies for high-risk cutaneous SCC.
© 2016 Wiley Periodicals, Inc. Head Neck 39: 578-594, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  American Joint Committee on Cancer (AJCC); National Comprehensive Cancer Network (NCCN); cutaneous squamous cell carcinoma (SCC); deep margin; immunosuppression; parotid; sentinel lymph node biopsy

Mesh:

Year:  2016        PMID: 27882625     DOI: 10.1002/hed.24580

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  21 in total

1.  MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.

Authors:  Shanshan Li; Chengqun Luo; Jun Zhou; Yong Zhang
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

Review 2.  Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications.

Authors:  Daniella Karassawa Zanoni; Snehal G Patel; Jatin P Shah
Journal:  Curr Oncol Rep       Date:  2019-04-17       Impact factor: 5.075

3.  Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness.

Authors:  Wei Wang; Eric Jorgenson; Alice S Whittemore; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

4.  Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.

Authors:  Ying Lu; Dagui Chen; Jinhui Liang; Jianquan Gao; Zhanxiong Luo; Rensheng Wang; Wenqi Liu; Changjie Huang; Xuejian Ning; Meilian Liu; Haixin Huang
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

Review 5.  Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of Immunotherapies.

Authors:  Priscila Oliveira de Lima; Shannon Joseph; Benedict Panizza; Fiona Simpson
Journal:  Curr Treat Options Oncol       Date:  2020-02-03

6.  A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib.

Authors:  Ahmad I Aleisa; John G Plante; Ling-Lun B Hsia
Journal:  JAAD Case Rep       Date:  2020-06-16

Review 7.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

8.  Significance of SUV Max for Predicting Occult Lymph Node Metastasis and Prognosis in Early-Stage Tongue Squamous Cell Carcinoma.

Authors:  Chunmiao Xu; Hailiang Li; Dongjie Seng; Fei Liu
Journal:  J Oncol       Date:  2020-03-30       Impact factor: 4.375

9.  Lingual Lymph Node Metastasis in cT1-2N0 Tongue Squamous Cell Carcinoma: Is It an Indicator for Elective Neck Dissection.

Authors:  Wenli Yang; Minglei Sun; Qiaoyan Jie; Haixia Zhou; Peng Zhang; Juanfang Zhu
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

10.  Recommendations on dermatologic surgery during the COVID-19 pandemic.

Authors:  Samuel Antranig Der Sarkissian; Leo Kim; Michael Veness; Eleni Yiasemides; Deshan Frank Sebaratnam
Journal:  J Am Acad Dermatol       Date:  2020-04-10       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.